Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Parkinson's Disease Mechanisms and Treatments

146 ta ish

  1. Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations

    Jamoliddin Razzokov, Sunnatullo Fazliev, Mukhriddin Makhkamov +3

    MaqolaParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20235 iqtibos
    ABI

  2. Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism

    D. Akramova, G. Rakhimbaeva

    MaqolaNuclear Receptors and SignalingParkinsonism & Related Disorders20181 iqtibos
    ABI

  3. New methods of treatment for vascular Parkinsonism and Parkinson's disease: Tempo-rhythmal correction combined with special exercise and music

    D. Akramova, G. Rakhimbaeva

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  4. Role of increased levels of endothelial factors in cognitive impairment in the Parkinson’s disease and vascular parkinsonism

    D. Akramova, G. Rakhimbaeva

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  5. Metabolically induced intracellular pH changes activate mitophagy, autophagy, and cell protection in familial forms of Parkinson's disease

    Nafisa R. Komilova, Plamena R. Angelova, Alexey V. Berezhnov +6

    MaqolaAutophagy in Disease and TherapyFEBS Journal20211 iqtibos
    ABI

  6. EVALUATION OF PRODROMAL STAGE BIOMARKERS IN PARKINSON'S DISEASE AND THEIR ROLE IN DISEASE PROGRESSION USE OF MODERN DIGITAL TECHNOLOGIES

    Khilola Maratovna Daminova, R. Matmurodov, D. Akramova +7

    MaqolaParkinson's Disease Mechanisms and Treatments20221 iqtibos
    ABI

  7. Exploring α-synuclein stability under the external electrostatic field: Effect of repeat unit

    Javokhir Khursandov, Rasulbek Mashalov, Mukhriddin Makhkamov +3

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of Structural Biology20241 iqtibos
    ABI

  8. The influence of robotics and modern technologies to assist individuals with Parkinson's disease

    A. Kim, L. Alimbekova

    MaqolaNeurological disorders and treatmentsParkinsonism & Related Disorders20241 iqtibos
    ABI

  9. Initial manifestations of Parkinson's disease in Uzbek nationality

    R. Juraev, E. Abdukodirov, R. Matmurodov +1

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  10. Gastrointestinal disturbances in various forms of parkinsonism

    O. Naimov, R. Matmurodov, E. Abdukodirov

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  11. Cardiovascular disorders in parkinsonism depending on the form of the disease

    R. Matmurodov, K. Khalimova, E. Abdukodirov

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  12. Constipation as a predictor of Parkinson's disease in persons of Uzbek nationality

    O. Naimov, E. Abdukodirov, R. Matmurodov +1

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  13. Character changes as a predictor of Parkinson’s disease in persons of Uzbek nationality

    R. Matmurodov, K. Khalimova, E. Abdukodirov

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos
    ABI

  14. Sleep disorders as a predictor of Parkinson's disease in Uzbek nationality

    B. Amonov, Rustambek Matmurodov, E. Abdukodirov +1

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20211 iqtibos
    ABI

  15. Psychosis in a Case of Schizophrenia and Parkinson’s Disease

    Benedikt Habermeyer, Stefan Kneifel, Irene Lotz-Bläuer +1

    BoshqaNeurological disorders and treatmentsJournal of Neuropsychiatry20080 iqtibos
    ABI

  16. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease

    Masaaki Waragai, Kazunari Sekiyama, Akio Sekigawa +3

    Sharh maqolaParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20100 iqtibos
    ABI

  17. Akiramine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobParkinson's Disease Mechanisms and Treatments20120 iqtibos
    ABI

  18. Norbracteoline

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobCancer Treatment and Pharmacology20120 iqtibos
    ABI

  19. 14-Dehydrotalatisamine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobParkinson's Disease Mechanisms and Treatments20120 iqtibos
    ABI

  20. Cyclolicorisoflavan-A

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobParkinson's Disease Mechanisms and Treatments20120 iqtibos
    ABI

  21. Ungeremine (Licobetaine)

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobPharmacology and Obesity Treatment20120 iqtibos
    ABI

  22. Violation of metabolism of nitric oxide in patients with Parkinson's disease and vascular parkinsonism

    Rustambek Matmurodov, K. Khalimova, M.M. Raimova

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20130 iqtibos
    ABI

  23. Estimation of the caused skin vegetative potentials in patients with Parkinson's disease

    Y.N. Madjidova, S.R. Fahargalieva

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20130 iqtibos
    ABI

  24. The importance of Ishihara Testing in early diagnosing of Parkinson disease

    S. Mirdedaev

    MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20150 iqtibos
    ABI

  25. EEG features of dyskinesias, complicated by levodopa therapy in patients with Parkinson's disease.

    Ulugbek Askhonov, Bahtiyar Gafurov, Gulomqodir Ashanov

    MaqolaAttention Deficit Hyperactivity DisorderParkinsonism & Related Disorders20150 iqtibos
    ABI